The major Epstein-Barr virus (EBV) envelope glycoprotein gp340 when incorporated into Iscoms primes cytotoxic T-cell responses directed against EBV lymphoblastoid cell lines

Author: Wilson A.D.   Lovgren-Bengtsson K.   Villacres-Ericsson M.   Morein B.   Morgan A.J.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.17, Iss.9, 1999-03, pp. : 1282-1290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content